NOVA1 acts as an oncogene in osteosarcoma.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American journal of translational research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 29118907PMCID PMC5666054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation

  2017cited by this paper
• Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas

  2016cited by this paper
• MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.

  2016cited by this paper
• MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells

  2016cited by this paper
• MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR

  2016cited by this paper
• MicroRNA‑224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1

  2016cited by this paper
• miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells

  2015cited by this paper
• miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2)

  2015cited by this paper
• Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma

  2015cited by this paper
• MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1

  2015cited by this paper
• microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6

  2015cited by this paper
• miR-181c associates with tumor relapse of high grade osteosarcoma

  2015cited by this paper
• A large‐scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function

  2015cited by this paper
• Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

  2015cited by this paper
• Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro

  2015cited by this paper
• NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal

  2015cited by this paper
• MicroRNA‐339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1

  2015cited by this paper
• Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer

  2014cited by this paper
• Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial–mesenchymal transition

  2014cited by this paper
• High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma

  2014cited by this paper
• Nova1 is a master regulator of alternative splicing in pancreatic beta cells

  2014cited by this paper
• Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span

  2014cited by this paper
• RETRACTED ARTICLE: MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN

  2014cited by this paper
• MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma

  2014cited by this paper
• p53-Dependent Activation of microRNA-34a in Response to Etoposide-Induced DNA Damage in Osteosarcoma Cell Lines Not Impaired by Dominant Negative p53 Expression

  2014cited by this paper
• miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease

  2014cited by this paper
• Nova 1 is a master regulator of alternative splicing in pancreatic beta cells

  2014cited by this paper
• MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma

  2013cited by this paper
• Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients

  2009cited by this paper
• Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain.

  2009cited by this paper
• Post-transcriptional Regulation of Neuro-oncological Ventral Antigen 1 by the Neuronal RNA-binding Proteins ELAV*

  2008cited by this paper
• Evolution of Nova-Dependent Splicing Regulation in the Brain

  2007cited by this paper
• ANOVA, a putative astrocytic RNA-binding protein gene that maps to chromosome 19q13.3

  1997influential reference

• Bibliometric analysis of RNA-binding proteins in osteosarcoma: unraveling research trends and hotspots

  2025cites this paper
• Investigation of RNA-binding protein NOVA1 in silico: Comparison of the modern human V197 with the archaic I197 variant present in Neanderthals

  2024cites this paper
• Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification

  2022cites this paper
• Knockdown of NOVA1 inhibits inflammation and migration of asthmatic airway smooth muscle cells to regulate PTEN/Akt pathway by targeting PTBP1.

  2021cites this paper
• MiR‐146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro‐oncological ventral antigen‐1

  2020cites this paper
• LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis

  2020cites this paper
• NOVA1 expression is associated with clinicopathological characteristics and prognosis in patients with small cell lung cancer

  2020cites this paper
• LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis

  2020cites this paper
• LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.

  2019cites this paper
• TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.

  2019cites this paper
• MicroRNA‐193a‐5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1

  2018cites this paper